Fosun Pharma
E483513
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Fosun Pharma canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T4949170 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Fosun Pharma Context triple: [Fosun International, owns, Fosun Pharma]
-
A.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
D.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Fosun Pharma Target entity description: Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
A.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Sinopharm
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
D.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
-
E.
Eisai
Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
- F. None of above. chosen
Statements (52)
| Predicate | Object |
|---|---|
| instanceOf |
Chinese company
ⓘ
pharmaceutical company ⓘ public company ⓘ |
| businessActivity |
active pharmaceutical ingredients
ⓘ
biopharmaceuticals ⓘ diagnostic products ⓘ drug distribution ⓘ drug manufacturing ⓘ generic drugs ⓘ healthcare services ⓘ hospital operation ⓘ innovative drugs ⓘ medical device manufacturing ⓘ over-the-counter medicines ⓘ pharmaceutical research and development ⓘ vaccines ⓘ |
| collaboratesWith | BioNTech NERFINISHED ⓘ |
| coreBusinessArea |
health management and insurance
ⓘ
healthcare services and hospitals ⓘ medical devices and diagnostics ⓘ pharmaceutical distribution and retail ⓘ pharmaceutical manufacturing ⓘ |
| country | China ⓘ |
| foundedBy |
Fosun Group
NERFINISHED
ⓘ
Guo Guangchang NERFINISHED ⓘ |
| hasSubsidiary |
Chongqing Yaoyou Pharmaceutical
NERFINISHED
ⓘ
Fosun Kite Biotechnology NERFINISHED ⓘ Fosun United Health Insurance NERFINISHED ⓘ Gland Pharma NERFINISHED ⓘ Jiangsu Chia Tai Fenghai Pharmaceutical NERFINISHED ⓘ Jiangsu Wanbang Biopharmaceuticals NERFINISHED ⓘ Shanghai Fosun Diagnostics NERFINISHED ⓘ Shanghai Fosun Long March Medical Science NERFINISHED ⓘ Shanghai Fosun Pharmaceutical Industrial Development NERFINISHED ⓘ Shanghai Henlius Biotech NERFINISHED ⓘ Sisram Medical NERFINISHED ⓘ |
| headquartersLocation | Shanghai NERFINISHED ⓘ |
| industry |
biotechnology
ⓘ
healthcare ⓘ hospital services ⓘ medical devices ⓘ pharmaceuticals ⓘ |
| parentCompany | Fosun International NERFINISHED ⓘ |
| productType |
anti-infective drugs
ⓘ
cardiovascular drugs ⓘ immunology drugs ⓘ metabolic disease drugs ⓘ oncology drugs ⓘ |
| stockExchange |
Hong Kong Stock Exchange
NERFINISHED
ⓘ
Shanghai Stock Exchange NERFINISHED ⓘ |
| tickerSymbol |
02196
ⓘ
600196 ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Fosun Pharma Description of subject: Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.